Methods for treating cerebrovascular disease comprising administering an agent that inhibits prokineticin receptor activity
US8101158B1 · kind B1 · utility
0Cited by
1References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 4, 2008 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Sep 20, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method of identifying agents that modulate prokineticin receptors, particularly, in the brain. Such agents are useful in the treatment of cerebrovascular diseases, including cerebral ischemia, cerebral hemorrhage, ischemic stroke, hemorrhagic stroke, and ischemic reperfusion injury. Additionally, such agents are useful to treat seizure disorders, such as epilepsy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.